{"filing":{"accession_number":"0001493152-26-027499","cik":"0001857044","ticker":"INDP","company_name":"Indaptus Therapeutics, Inc.","form":"8-K","filing_date":"2026-06-05","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1857044/000149315226027499/form8-k.htm"},"events":[{"id":3851,"run_id":3375,"accession_number":"0001493152-26-027499","anchor_item_number":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses the resignation of two directors (David E. Lazar and Avraham Ben-Tzvi, effective June 5, 2026) and the Chief Operating Officer (Walt A. Linscott, effective June 1, 2026). While Linscott transitions to a consulting role, the primary disclosed action is the departure of these executives from their positions. The filing explicitly states these resignations were not due to disagreement, but the simultaneous departure of multiple board members and a C-suite officer is material to investors assessing governance and leadership continuity.","company_name":"Indaptus Therapeutics, Inc.","ticker":"INDP","filing_date":"2026-06-05","items":null}],"classifications":[{"id":4875,"accession_number":"0001493152-26-027499","item_number":null,"item_title":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the resignation of two directors (David E. Lazar and Avraham Ben-Tzvi, effective June 5, 2026) and the Chief Operating Officer (Walt A. Linscott, effective June 1, 2026). While Linscott transitions to a consulting role, the primary disclosed action is the departure of these executives from their positions. The filing explicitly states these resignations were not due to disagreement, but the simultaneous departure of multiple board members and a C-suite officer is material to investors assessing governance and leadership continuity.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T20:33:37.386778+00:00","company_name":"Indaptus Therapeutics, Inc.","ticker":"INDP","filing_date":"2026-06-05"}]}